We are live on ! Find out more
OCUL icon

Ocular Therapeutix
OCUL

149 hedge funds and large institutions have $685M invested in Ocular Therapeutix in 2021 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 59 increasing their positions, 35 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

120% more call options, than puts

Call options by funds: $24.5M | Put options by funds: $11.1M

69% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 35

1.29% more ownership

Funds ownership: 62.11% → 63.4% (+1.3%)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

3% less funds holding

Funds holding: 154 → 149 (-5)

12% less capital invested

Capital invested by funds: $774M → $685M (-$89.5M)

18% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 28

Holders
149
Holders Change
-5
Holders Change %
-3.25%
% of All Funds
2.59%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
23
Increased
59
Reduced
35
Closed
28
Calls
$24.5M
Puts
$11.1M
Net Calls
+$13.3M
Net Calls Change
+$12.2M

Top Buyers

Rank Fund Capital Flow
1
RCMNY
Rubric Capital Management (New York)
New York
+$27M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$15.4M
3
KCM
Kornitzer Capital Management
Kansas
+$8.53M
4
AS
Altshuler Shaham
Israel
+$8.22M
5
Renaissance Technologies
Renaissance Technologies
New York
+$4.21M

Top Sellers

Rank Fund Capital Flow
1
Victory Capital Management
Victory Capital Management
Texas
-$23.4M
2
BlackRock
BlackRock
New York
-$13.5M
3
CM
Castleark Management
Illinois
-$7.97M
4
Wells Fargo
Wells Fargo
California
-$7.04M
5
Federated Hermes
Federated Hermes
Pennsylvania
-$5.14M
Name Holding Trade Value Shares
Change 		Change in
Stake
California Public Employees Retirement System
151
California Public Employees Retirement System
California
– -$2.02M -123,000 Closed
SEI Investments
152
SEI Investments
Pennsylvania
– -$1.48M -75,250 Closed
EMG
153
ETF Managers Group
New Jersey
– -$1.19M -74,388 Closed
DI
154
DUMAC Inc
North Carolina
– -$941K -57,359 Closed
E
155
Ergoteles
New York
– -$849K -51,726 Closed
OMC
156
Old Mission Capital
Illinois
– -$600K -36,588 Closed
Creative Planning
157
Creative Planning
Kansas
– -$428K -26,083 Closed
GAM
158
Gotham Asset Management
New York
– -$401K -24,438 Closed
Balyasny Asset Management
159
Balyasny Asset Management
Illinois
– -$274K -16,704 Closed
SG Americas Securities
160
SG Americas Securities
New York
– -$247K -15,072 Closed
CL
161
CSS LLC
Illinois
– -$243K -14,814 Closed
Los Angeles Capital Management
162
Los Angeles Capital Management
California
– -$218K -13,285 Closed
AC
163
Athanor Capital
New York
– -$191K -11,644 Closed
AGM
164
Alpine Global Management
New York
– -$178K -10,876 Closed
JCM
165
JS Capital Management
New York
– -$172K -10,500 Closed
MSL
166
Mackay Shields LLC
New York
– -$169K -10,300 Closed
Bank of Montreal
167
Bank of Montreal
Ontario, Canada
– -$56K -3,397 Closed
IA
168
IFP Advisors
Florida
– -$22.8K -1,500 Closed
MAM
169
Meeder Asset Management
Ohio
– -$22K -1,362 Closed
VFA
170
Valeo Financial Advisors
Indiana
– -$16K -1,000 Closed
TCWM
171
Total Clarity Wealth Management
Illinois
– -$15K -930 Closed
PFGIA
172
Patriot Financial Group Insurance Agency
Massachusetts
– -$6.08K -400 Closed
SFS
173
Sowell Financial Services
Arkansas
– -$3K -200 Closed
ADIM
174
Alpha DNA Investment Management
Maryland
– -$2K -127 Closed
TWA
175
TCI Wealth Advisors
Arizona
– -$2K -99 Closed
3 4 5 6
7

OCUL Hedge Fund Activity: Q2 2021 in Review

149 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Ocular Therapeutix (OCUL) for Q2 2021, worth a combined $685M — down 12% from $774M a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of OCUL and 23 opened new positions — a net loss of 5 holders — while 35 trimmed existing stakes and 59 added.

The largest buyer was Rubric Capital Management (New York), adding an estimated $27M. The largest seller was Victory Capital Management, cutting an estimated $23.4M.

  • 149 institutional investors held Ocular Therapeutix (OCUL) as of Q2 2021, down from 154 in Q1 2021.
  • Funds reported $685M of Ocular Therapeutix stock for Q2 2021, down 12% quarter-over-quarter.
  • 23 funds opened new Ocular Therapeutix positions in Q2 2021 and 28 closed out, a net change of -5 holders.
  • The largest Ocular Therapeutix buyer in Q2 2021 was Rubric Capital Management (New York), an estimated $27M added.
  • The largest Ocular Therapeutix seller in Q2 2021 was Victory Capital Management, an estimated $23.4M sold.

Based on aggregated 13F filings for Q2 2021.